Rethinking Parkinson's: Immune insights from brain-resident and peripheral cells offer new therapeutic hopes
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Jun-2026 12:16 ET (2-Jun-2026 16:16 GMT/UTC)
Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve significant immune dysfunction within and outside the central nervous system (CNS). A new review by Professor Qiang Liu's team at Tianjin Medical University General Hospital synthesizes evidence that dynamic interactions between brain-resident and peripheral immune cells are crucial in diseases like Parkinson's disease (PD), offering fresh perspectives for developing treatments that can modify disease progression.
Drugs that act against bacteria are mainly assessed based on how well they inhibit bacterial growth under laboratory conditions. A critical factor, however, is whether the active substances actually kill the pathogens in the body. Researchers at the University of Basel have presented a new method for measuring how effectively antibiotics kill bacteria.
Potentially more than 90% of Alzheimer’s disease cases would not occur without the contribution of a single gene (APOE), according to a new analysis led by University College London (UCL) researchers.
Patients with chronic illnesses face a significantly higher risk of complications from cosmetic botulinum toxin injections, commonly known as Botox, according to a major UK study.